Tiantian Cui
0000-0003-0651-7193
Publication & Citation Trends
Publications
0 total
Abstract 2407: Targeting ribonucleotide reductase subunit 2 (RRM2) to radio-sensitize glioblastoma
Cited by 0
Semantic Scholar
Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1.
Cited by 17
Semantic Scholar
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways OA
Cited by 9
Semantic Scholar
A Comparison of Clinical Features of Youth with and without Rhinitis Signs and Symptoms Who Are Hospitalized for Headache OA
Cited by 1
Semantic Scholar
MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma. OA
Cited by 4
Semantic Scholar
A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors OA
Cited by 11
Semantic Scholar
Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume OA
Cited by 5
Semantic Scholar
Research Topics
Chromatin Remodeling and Cancer
(45)
MicroRNA in disease regulation
(40)
Mechanisms of cancer metastasis
(37)
Circular RNAs in diseases
(22)
Cancer Mechanisms and Therapy
(17)
Affiliations
South China Agricultural University
Shenyang Pharmaceutical University
Zhejiang A & F University
City Of Hope National Medical Center
Guiyang Medical University